Insulin resistance is a primary pathological mechanism causing both MASLD and sarcopenia, initiating from skeletal muscle loss and leading to increased lipolysis and dysregulation of the GH/IGF-1 axis (38). Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.